Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study

Inhibitor Therapy ◽

Factor Inhibitor ◽

I122. REAL-WORLD EFFECTIVENESS OF TUMOUR NECROSIS FACTOR INHIBITOR IN ANKYLOSING SPONDYLITIS

Rheumatology ◽

10.1093/rheumatology/kex060.122 ◽

2017 ◽

Vol 56 (suppl_2) ◽

Author(s):

Gareth T. Jones

Keyword(s):

Ankylosing Spondylitis ◽

Tumour Necrosis Factor ◽

Real World ◽

Tumour Necrosis ◽

Factor Inhibitor ◽

FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study

10.1136/annrheumdis-2017-eular.4787 ◽

2017 ◽

Author(s):

J Rech ◽

M Hagen ◽

M Englbrecht ◽

J Haschka ◽

M Reiser ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Sustained Remission ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical & Experimental Immunology ◽

10.1111/cei.12161 ◽

2013 ◽

Vol 174 (1) ◽

pp. 18-26 ◽

Cited By ~ 23

Author(s):

S. Ceeraz ◽

C. Hall ◽

E. H. Choy ◽

J. Spencer ◽

V. M. Corrigall

Keyword(s):

Rheumatoid Arthritis ◽

T Cell ◽

Tumour Necrosis Factor ◽

Regulatory T Cell ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Suppressor Function ◽

Factor Inhibitor ◽

The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor- inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China

Rheumatology ◽

10.1093/rheumatology/ker087 ◽

2011 ◽

Vol 50 (8) ◽

pp. 1466-1472 ◽

Cited By ~ 23

Author(s):

M. Xu ◽

Z. Lin ◽

X. Deng ◽

L. Li ◽

Y. Wei ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Disease Activity Score ◽

Activity Score ◽

Factor Inhibitor ◽

248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy

Rheumatology ◽

10.1093/rheumatology/kez107.064 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Deepak R Jadon ◽

Mani Haschemi Nassab ◽

Katrien Van Beneden ◽

Georg Pum ◽

Andrew J Bradley

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Inadequate Response ◽

Factor Inhibitor ◽

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-201999 ◽

2012 ◽

Vol 71 (12) ◽

pp. 2002-2005 ◽

Cited By ~ 60

Author(s):

Pedro Machado ◽

Robert B M Landewé ◽

Jürgen Braun ◽

Xenofon Baraliakos ◽

Kay-Geert A Hermann ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Clinical Disease ◽

Clinical Disease Activity ◽

Factor Inhibitor ◽

Treatment Responses ◽

Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

Rheumatology ◽

10.1093/rheumatology/keu255 ◽

2014 ◽

Vol 54 (1) ◽

pp. 152-156 ◽

Cited By ~ 23

Author(s):

D. Wallis ◽

A. Thavaneswaran ◽

N. Haroon ◽

R. Ayearst ◽

R. D. Inman

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Infection Risk ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Observational Cohort ◽

OP0106 The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2017-eular.1500 ◽

2017 ◽

Author(s):

C Ballegaard ◽

P Højgaard ◽

L Dreyer ◽

R Cordtz ◽

TS Jørgensen ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

The Impact ◽

THU0332 Fatigue remains a dominatng symptom despite tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2018-eular.6780 ◽

2018 ◽

Cited By ~ 1

Author(s):

T.S. Jørgensen ◽

M. Skougaard ◽

C. Ballegaard ◽

P. Mease ◽

V. Strand ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

OP0289 Comorbidity with Depression and Anxiety is Associated with Discontinuation of Tumour Necrosis Factor Inhibitor (TNFI) Therapy in Ankylosing Spondylitis (AS)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.4533 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 181.3-182

Author(s):

E. Lie ◽

U. Lindström ◽

L.E. Kristensen ◽

H. Forsblad-d'Elia ◽

J. Askling ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Depression And Anxiety ◽

Factor Inhibitor ◽